The provision of safe meat is a universal problem. KAKETSUKEN handled the development of vaccines against hog cholera, fowl pox, and Newcastle disease and so on at the dawn of stock farming in Japan, playing an important role in the prevention of acute infectious diseases. However, due to the circumstances of increasing large-scale farms and greater international competition, demand increased for vaccines to treat chronic infectious diseases at a lower cost. In addition, with the improvement of public awareness about health, the demand for safe eggs and meat increased, and needs shifted from medical treatment with antibiotics to prevention with vaccines.
Responding to such demands, KAKETSUKEN succeeded in the development of "Oilvax ," Japan's first combined oil-adjuvanted vaccine for fowl, which drastically prolong the protection period with humoral immunity. To meet the market's demands for convenience, a high number of polyvalent vaccines is important; in addition to the Oilvax series of three-way and four-way products, the highly anticipated five-way, six-way, and seven-way vaccines are in the market. The development of the fowl salmonella vaccine, which also has the effect of preventing food poisoning in humans, and vector vaccines, to which genetic recombinant technology is applied for the coming generation, are also important themes of today.
Vaccines for animals cover a fairly broad spectrum including those for pigs, cattle, horses, dogs, and cats, in addition to those for fowl. We have recently put a great deal of effort into product development for pigs. In addition to our core vaccines against porcine reproductive and respiratory syndrome (PRRS), porcine atrophic rhinitis (AR), and mycoplasmal pneumoniae of swine, we have pursued the development of combined vaccines including the combination of vaccines against swine erysipelas, pasteurella, porcine epidemic diarrhea (PED), and transmissible gastroenteritis of swine (TGE). In addition to the above, the three-way against bovine viral congenital abnormality, Akabane disease vaccine, and the rabies vaccine for dogs are available, and even vaccine for horses was developed. The Aso Laboratory supports an infallible supply system of high quality vaccines by way of breeding various specific pathogen free (SPF) animals used for vaccine materials and for quality control tests.
Even regarding the development of pharmaceuticals for animals, the need for products of high quality is rising year by year. KAKETSUKEN, in order to supply high quality products with improved effectiveness, will continue contributing to the stable supply and hygenic improvement in stock farm products, sanitation by producing products, with the lastest style of facilities adapted to Good Manufacturing Practice (GMP) standards.